Anti-C5 / C5a 抗体 [557] (ab11876)
Key features and details
- Mouse monoclonal [557] to C5 / C5a
- Suitable for: WB, Inhibition Assay, Functional Studies, ELISA
- Reacts with: Human
- Isotype: IgG2a
リコンビナント抗体で、ロット間での高い再現性を実現
- 異なるロット間での安定した再現性
- 容易なスケールアップ
- 評価試験による特異性の確認済み
- 倫理基準に準拠 - アニマル・フリーの生産
製品の概要
-
製品名
Anti-C5 / C5a antibody [557]
C5 / C5a 一次抗体 製品一覧 -
製品の詳細
Mouse monoclonal [557] to C5 / C5a -
由来種
Mouse -
特異性
This antibody reacts with an epitope on C5 and C5a. The antibody 557 is capable to inhibit the binding of C5a to the C5a receptor through a competitive mechanism, it does not block the cleavage of C5 into C5a and C5b. -
アプリケーション
適用あり: WB, Inhibition Assay, Functional Studies, ELISAmore details -
種交差性
交差種: Human -
免疫原
Other Immunogen Type corresponding to Human C5/ C5a.
Database link: P01031 -
エピトープ
Ab11876 recognizes an epitope located within the alpha-chain of C5 that corresponds to C5a. -
ポジティブ・コントロール
- Recombinant C5
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
バッファー
Constituents: PBS, 0.1% BSA -
Concentration information loading...
-
精製度
Protein G purified -
特記事項(精製)
0.2 µm filtered -
ポリ/モノ
モノクローナル -
クローン名
557 -
アイソタイプ
IgG2a -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab11876の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
Use at an assay dependent concentration.
|
|
Inhibition Assay |
Use at an assay dependent concentration.
|
|
Functional Studies |
Use at an assay dependent concentration.
|
|
ELISA | (1) |
Use at an assay dependent concentration.
|
特記事項 |
---|
WB
Use at an assay dependent concentration. |
Inhibition Assay
Use at an assay dependent concentration. |
Functional Studies
Use at an assay dependent concentration. |
ELISA
Use at an assay dependent concentration. |
ターゲット情報
-
機能
Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.
Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. C5a also stimulates the locomotion of polymorphonuclear leukocytes (chemokinesis) and direct their migration toward sites of inflammation (chemotaxis). -
関連疾患
Complement component 5 deficiency
An association study of C5 haplotypes and genotypes in individuals with chronic hepatitis C virus infection shows that individuals homozygous for the C5_1 haplotype have a significantly higher stage of liver fibrosis than individuals carrying at least 1 other allele (PubMed:15995705). -
配列類似性
Contains 1 anaphylatoxin-like domain.
Contains 1 NTR domain. -
細胞内局在
Secreted. - Information by UniProt
-
参照データベース
- Entrez Gene: 727 Human
- Omim: 120900 Human
- SwissProt: P01031 Human
- Unigene: 494997 Human
-
別名
- Anaphylatoxin C5a analog antibody
- C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 antibody
- C5 antibody
see all
データシートおよび資料
-
Datasheet download
参考文献 (6)
ab11876 は 6 報の論文で使用されています。
- Garcia-Arguinzonis M et al. Alternative C3 Complement System: Lipids and Atherosclerosis. Int J Mol Sci 22:N/A (2021). PubMed: 34066088
- Peng L et al. A Novel Cleavage Pattern of Complement C5 Induced by Chlamydia trachomatis Infection via the Chlamydial Protease CPAF. Front Cell Infect Microbiol 11:732163 (2021). PubMed: 35087765
- Yuan K et al. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. J Exp Clin Cancer Res 39:9 (2020). PubMed: 31928530
- Lu W et al. C5a aggravates dysfunction of the articular cartilage and synovial fluid in rats with knee joint immobilization. Mol Med Rep 18:2110-2116 (2018). PubMed: 29956782
- Wangdi T et al. The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxis. PLoS Pathog 10:e1004306 (2014). Mouse, Human . PubMed: 25101794
- Kola A et al. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis. Immunotechnology 2:115-26 (1996). PubMed: 9373320